BML Investment Partners, L.P. - 31 Mar 2025 SCHEDULE 13G/A Report for Adverum Biotechnologies, Inc. Common Stock, par value $0.0001 per share (ADVM)

Filing Manager: BML Investment Partners, L.P.
Reporting Manager: Leonard Braden Michael
Security: Adverum Biotechnologies, Inc. Common Stock, par value $0.0001 per share
Symbol: ADVM
Shares outstanding: 20,886,355 shares
Disclosed Ownership: 2,882,317 shares
Ownership: 14%
Form type: SCHEDULE 13G/A
Filing time: 06 May 2025, 09:15:54 UTC
Date of event: 31 Mar 2025
Previous filing: 13 Feb 2025
Next filing: 20 May 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BML Investment Partners, L.P.	13%	2,742,317	0	2,742,317	Braden M Leonard	BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member
Leonard Braden Michael	14%	2,882,317	140,000	2,742,317	Braden M Leonard	Leonard Braden Michael